What We're Reading: Page 125
Industry reads hand-picked by our editors
Feb 17, 2022
-
Associated Press
Biden tapping 2 to step in for ousted science adviser
-
Financial Times
Merck struggles to win European approval for Covid antiviral pill
-
Nature
NIH issues a seismic mandate: share data publicly
-
IEEE Spectrum
Their Bionic Eyes Are Now Obsolete and Unsupported
Feb 16, 2022
Feb 15, 2022
Feb 14, 2022
-
The Financial Times
Moderna in talks to set up UK research and manufacturing
-
Bloomberg
Biotech Money Shock: Investors Unwind Speculative Bets as Pandemic Fears Fade
-
Chemical & Engineering News
Francis Collins on diversity, politics, and his legacy
-
Endpoints News
Eli Lilly and Roche ask CMS not to be lumped in with Aduhelm's restrictive judgment
Feb 11, 2022
-
STAT
Senate pushes toward a vote on Robert Califf, Biden’s pick for FDA
-
The Wall Street Journal
FDA Rejects Short Sellers' Request to Halt Trials of Alzheimer's Drug
-
The New York Times
Luc Montagnier, Nobel-Winning Co-Discoverer of H.I.V., Dies at 89
Feb 10, 2022
-
The Financial Times
Biotechs face cash crunch after stock market ‘bloodbath’
-
Associated Press
Biden puts focus on drug prices as he tries to revive agenda
-
FirstWord Pharma
US lawmakers urge HHS to step in over price of Astellas' Xtandi
-
MIT Technology Review
Meet the scientist at the center of the covid lab leak controversy
Feb 09, 2022
-
Bloomberg
Glaxo Expects Profit to Rise as Drugmaker Prepares for Split
-
Associated Press
FDA's agenda in limbo as Biden's nominee stalls in Senate
-
Endpoints News
With first human data, long-struggling Silence Therapeutics leaps into next big cardiovascular race
-
FierceBiotech
Seismic emerges with $101M, Harvard billionaire founder and leadership team fresh off $1.9B exit
Previous
